TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Amrutajan Health Ltd
AMRUTANJAN

Amrutajan Health Ltd Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 63/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹506.35

Change

-3.85 (-0.75%)

Open

₹510.2

Prev. Close

₹510.2

Day High

₹514.9

Day Low

₹500.6

Volume Analysis

Traded

16,785

Delivered

8,963

Delivery %

53.4%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong return on equity (20.0%)

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (2)

  • •Strong 3-year EPS growth (26.7%)
  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹528.26 ₹521.58 ₹513.96 ₹507.28 ₹499.66 ₹492.98 ₹485.36
Fibonacci ₹521.58 ₹516.12 ₹512.74 ₹507.28 ₹501.82 ₹498.44 ₹492.98
Camarilla ₹510.28 ₹508.97 ₹507.66 ₹507.28 ₹505.04 ₹503.73 ₹502.42

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-24.11%

1 Week

+2.08%

1 Month

-1.54%

3 Months

-7.59%

6 Months

+1.37%

1 Year

-30.19%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹76.82

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

19.13%

Net margin 11.86% × asset turnover 1.26x × equity multiplier 1.28x

Company Overview

Sector

Healthcare

Market Cap

₹1,480 Cr

P/E (TTM)

72.6

ROE

20.0%

Book Value

₹37.2

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.

TopFund Analysis

Amrutajan Health Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Financial Strength (100/100), while Valuation (4/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (20.0%); promoter holding is falling. Strong 3-year EPS growth (26.7%).

TopFund Score — Fundamentals Quality

63/100 — Average

Data confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

100

Growth

70

Valuation

4

Cash Flow

69

Corporate Governance

76

Momentum

13

Institutional Ownership

60

Business Quality

82

Risk & Volatility

88

Liquidity

34

From Screener.in

  • +Company is almost debt free.
  • +Company has been maintaining a healthy dividend payout of 33.0%
  • −Stock is trading at 13.8 times its book value
  • −The company has delivered a poor sales growth of 11.8% over past five years.
  • −Promoter holding has decreased over last 3 years: -3.51%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 24 Sep 24 Sep
Shareholder Meeting / Postal Ballot-Outcome of AGM 23 Sep

89th AGM held September 23, 2026; shareholders approved FY26 accounts, Rs.2.90 final dividend, and director reappointment.

Business Responsibility and Sustainability Reporting (BRSR) 28 Aug

Amrutanjan filed FY26 BRSR and AGM notice; final dividend ₹2.90/share, record date Sept. 11, 2026.

Reg. 34 (1) Annual Report. 28 Aug

Submitted FY2025-26 annual report; 89th AGM on 23 Sept 2026; final dividend ₹2.90 per share.

Investor Presentation For The Quarter Ended 30Th June 2026 12 Aug 12 Aug

Source: BSE regulatory filings, via Screener.in.

Profit & Loss (Yearly)

  Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Sales + 67 69 71 87 86 101 136 131 134 158 177
Expenses + 53 53 60 182 76 88 118 113 112 134 145
Operating Profit 13 16 11 -95 10 13 18 17 22 24 31
OPM % 20.0% 23.0% 16.0% -109.0% 12.0% 13.0% 13.0% 13.0% 16.0% 15.0% 18.0%
Other Income + 1 -2 0 220 10 5 4 4 3 4 5
Interest 1 1 1 0 0 1 3 2 2 1 0
Depreciation 3 2 2 2 1 2 3 4 4 3 3
Profit before tax 11 11 9 123 19 15 16 15 19 24 33
Tax % 45.0% 46.0% 42.0% 25.0% 38.0% 34.0% 39.0% 35.0% 36.0% 38.0% 37.0%
Net Profit + 6 6 5 92 11 10 10 10 12 15 21
EPS in Rs — — — 30 — — 3 3 4 5 7
Dividend Payout % 22.0% 32.0% 45.0% 19.0% 40.0% 45.0% 45.0% 43.0% 38.0% 34.0% 27.0%

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Reserves 15 20 23 90 94 98 74 79 86 92 106
Borrowings + 6 8 8 1 1 30 22 15 8 2 2
Other Liabilities + 13 10 14 17 20 26 25 27 23 26 29
Total Liabilities 37 41 48 111 118 157 124 124 120 124 140
Fixed Assets + 16 13 20 16 16 52 33 30 27 24 29
CWIP 0 3 3 2 7 0 1 1 1 4 1
Investments 0 0 0 0 46 42 29 25 9 9 9
Other Assets + 21 26 25 92 50 62 62 69 83 87 102
Total Assets 37 41 48 111 118 157 124 124 120 124 140
Equity Capital 3 3 3 3 3 3 3 3 3 3 3

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Cash from Operating Activity + 10 11 5 6 11 6 4 9 17 18 21
Cash from Investing Activity + 3 -4 -8 89 -47 -29 14 13 16 -5 4
Cash from Financing Activity + -12 -1 -2 -30 -8 20 -27 -14 -14 -12 -13
Net Cash Flow 1 6 -5 65 -43 -4 -9 8 20 1 12
CFO/OP 103 116 61 -13 195 79 48 81 114 117 103
Free Cash Flow 12 7 -3 89 6 -5 0 8 17 13 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 50.59% → 46.52%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Others 0.18% 0.18% 0.07% 0.07% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
Public 41.39% 41.19% 40.66% 40.47% 40.5% 40.01% 39.75% 38.34% 38.16% 38.18% 38.61% 38.72%
Promoters 50.59% 50.59% 50.59% 50.58% 46.52% 46.52% 46.52% 46.52% 46.52% 46.52% 46.52% 46.52%
FII 0.75% 0.8% 1.38% 1.55% 2.34% 2.3% 2.3% 2.41% 2.38% 2.27% 2.17% 2.44%
DII 7.1% 7.24% 7.29% 7.32% 10.6% 11.13% 11.41% 12.7% 12.9% 13.0% 12.66% 12.29%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Amrutajan Health Ltd (this stock) 1,480 72.6 13.76 20.0%
Fermenta Biotech Ltd. 1,455 26.6 3.58 16.4%
Gujarat Kidney N Sup Sp L 1,398 88.3 5.53 11.1%
Kopran Ltd 1,378 55.2 2.6 4.91%
Shalby Limited 1,589 40.4 1.58 2.45%
Gpt Healthcare Limited 1,331 32.0 — 28.5%
Anlon Healthcare Limited 1,655 52.3 7.18 18.4%

Which Mutual Funds Hold Amrutajan Health Ltd?

Frequently Asked Questions about Amrutajan Health Ltd

Community Sentiment

What are other investors saying about Amrutajan Health Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.